Android app Apple app link

Oric Pharmaceuticals announces clinical supply agreement with Janssen

By Yahoo! Finance   |   1 day ago
Oric Pharmaceuticals announces clinical supply agreement with Janssen

ORIC Pharmaceuticals partners with Janssen to evaluate ORIC-114 and amivantamab for treating advanced NSCLC with EGFR mutations. ORIC will conduct the trial while Janssen supplies amivantamab.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.